Company: DHR
Filing Date: 2025-02-20
Form Type: 10-K
Source: 0000313616-25-000043
Chunk: 42

Company: DANAHER CORP /DE/
Filing Date: 2025-02-20
Form: 10-K
Item: Item 8
Chunk 42
---
314 $6,875 $37,276 Attributable to 2023 acquisitions— 3,851 — 3,851 Adjustments due to finalization of purchase price adjustments2 5 — 7 Foreign currency translation and other388 51 35 474 Balance, December 31, 202322,477 12,221 6,910 41,608 Attributable to 2024 acquisitions— 305 — 305 Adjustments due to finalization of purchase price allocations— (23)— (23)Foreign currency translation and other(1,040)(198)(155)(1,393)Balance, December 31, 2024$21,437 $12,305 $6,755 $40,497 Finite-lived intangible assets are amortized over their legal or estimated useful life.  The following summarizes the gross carrying value and accumulated amortization for each major category of intangible assets as of December 31 ($ in millions): 20242023 Gross CarryingAmountAccumulatedAmortizationGross CarryingAmountAccumulatedAmortizationFinite-lived intangibles:Patents and technology$14,781 $(4,641)$15,175 $(3,832)Customer relationships, trade names and other intangibles9,972 (4,781)10,131 (4,303)Total finite-lived intangibles24,753 (9,422)25,306 (8,135)Indefinite-lived intangibles:Trademarks and trade names3,237 — 3,575 — Total intangibles$27,990 $(9,422)$28,881 $(8,135)During 2024, the Company acquired finite-lived intangible assets, consisting primarily of developed technology, customer relationships and trade names, with a weighted average life of 11 years.  Refer to Note 2 for information on the intangible assets acquired.The Company reviews identified intangible assets for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable.  Indefinite-lived intangibles are subject to impairment testing at least annually or more frequently if events or changes in circumstances indicate that potential impairment exists.  During the third quarter of 2024, the Company concluded that it had an impairment indicator for an indefinite-lived trade name within the genomics consumable business included in